Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA

Kentaro To, Noriko Miyake, Yoji Nagasaki, Nobuyuki Shimono

研究成果: ジャーナルへの寄稿学術誌査読

1 被引用数 (Scopus)

抄録

Infective endocarditis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a serious disease and sometimes leads to poor prognosis. We should have several therapeutic options. Arbekacin is one of the aminoglycoside antibiotics, which is more active against MRSA and less nephrotoxic than gentamicin. Here we presented a successfully treated case of severe MRSA endocarditis without any adverse effect by monitoring therapeutic level of vancomycin and arbekacin.

本文言語英語
ページ(範囲)389-394
ページ数6
ジャーナルJapanese Journal of Antibiotics
64
6
出版ステータス出版済み - 12月 2011

!!!All Science Journal Classification (ASJC) codes

  • 微生物学(医療)
  • 薬理学(医学)
  • 感染症

フィンガープリント

「Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル